Publications

Shay EC, Panko JM. Community-focused remediation and risk assessment at a former manufactured gas plant site. Poster at Society of Environmental Toxicology and Chemistry, 34th Annual Meeting, Nashville, TN, November 2013.

Sacks NC, Burgess JF, Cabral HJ, Pizer SD, McDonnell, ME. 2013. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med 28(7):876–885; doi: 10.1007/s11606-013-2342-3. PMID: 23404199.

Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Childhood cancer incidence in Pennsylvania counties in relation to living in counties with hydraulic fracturing sites. J Occup Environ Med 55(7):796–801; doi: 10.1097/JOM.0b013e318289ee02. PMID: 23836020.

Kreider ML, Burns AM, DeRose GH, Panko JM. 2013. Protecting workers from risks associated with nanomaterials: Part I — Exposure assessment. Occup Health Saf 82(7):90-1,94. PMID: 23951851.

Dourson ML, Gadagbui B, Griffin S, Garabrant DH, Haws LC, Kirman C, Tohyama C. 2013. The importance of problem formulations in risk assessment: A case study involving dioxin-contaminated soil. Regul Toxicol Pharmacol 66(2):208-216; doi: 10.1016/j.yrtph.2013.03.010. PMID: 23545073.

Lai IK*, Klaren WD*, Li M, Wels B, Simmons DL, Olivier AK, Haschek WM, Wang K, Ludewig G, and Robertson LW. 2013. Does dietary copper supplementation enhance or diminish PCB126 toxicity in the rodent liver?  Chem Res Toxicol 26(5):634–644 (*Co-First Authors); doi: 10.1021/tx400049s. PMID: 23527585.

Urban JD, Thompson CM, Deskin R, Waite M, Haws LC. 2013. Development of an oral cancer slope factor for acrylamide based on tumors relevant to humans. Presented at Society of Toxicology 52nd Annual Meeting, San Antonio, TX, March 2013.

Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE. 2013. Exposures from chrysotile-containing joint compound: Evaluation of new model relating respirable dust to fiber concentrations. Risk Anal 33(1):161-176; doi: 10.1111/j.1539-6924.2012.01847.x. PMID: 22642316.

Panko JM, Chu J, Kreider ML, Unice KM. 2013. Measurement of airborne concentrations of tire and road wear particles in urban and rural areas of France, Japan, and the United States. Atmos Environ 72(June):192–199; doi: 10.1016/j.atmosenv.2013.01.040.

Kirman CR, Aylward LL, Suh M, Harris MA, Thompson CM, Haws LC, Proctor DM, Lin SS, et al. 2013. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chem Biol Interact 204(1):13-27; doi: 10.1016/j.cbi.2013.04.003. PMID: 23603453.

Meddings J, Reichert H, Grazier KL, Rogers MAM, Hofer T, McMahon LF. Effect of payment changes for pressure ulcers from the hospital-acquired conditions initiative: A statewide analysis. Presented at the 2013 AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013.

Meddings J, Reichert H, Rogers MAM, Hofer T, McMahon LF. Risk-adjusting hospital-acquired pressure ulcer rates from claims data: Teaching hospitals beware. Presented at the 2013 AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013.

Reichert H. Risk standardization. Presented at the Institute for Healthcare Policy and Innovation (IHPI) Methods Seminar, Ann Arbor, MI, June 2013.

Greene N, Gosink M. 2013. Computational toxicology experience and applications for risk assessment in the pharmaceutical industry. Chapter 10 in: Fowler BA (ed), Computational Toxicology: Methods and Applications. Elsevier-Academic Press, pp. 171-193; doi: 10.1016/B978-0-12-396461-8.00012-9.

Bylsma LC. Parental trust in health information sources and influenza vaccination in children. Presented at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference, Pasadena, CA, June 2013.

Robison TW. Regulatory review of XELJANZ® (Tofacitinib) from the nonclinical perspective. American College of Toxicology Annual Meeting, 2013.

Henderson R, Verougstraete V, Anderson K, Arbildua JJ, Brock TO, Brouwers T, Cappellini D, Delbeke K, et al. Interlaboratory comparison of bioaccessibility tests for metals. Annual Meeting of the Belgian Society for Toxicology and Ecotoxicology (BelTox), 2013.

Tvermoes BE, Finley BL, Unice KM, Otani JM, Paustenbach DJ, Galbraith DA. 2013. Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement. Food Chem Toxicol 53:432–439; doi: 10.1016/j.fct.2012.11.033. PMID: 23207477.

Paustenbach DJ, Tvermoes BE, Unice KM, Finley BL, Kerger BD. 2013. A review of the health hazards posed by cobalt. Crit Rev Toxicol 43(4):316–362; doi:10.3109/10408444.2013.779633. PMID: 23656559.

Kerger BD, Tvermoes BE, Unice KM, Finley BL, Paustenbach DJ, Galbraith DA. 2013. Cobalt speciation assay for human serum, Part II. Method validation in a study of human volunteers ingesting cobalt (II) chloride dietary supplement for 90 days. Toxicol Environ Chem 95(4):709–718; doi: 10.1080/02772248.2013.792559.